Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 1
1931 1
1932 1
1951 1
1952 1
1972 2
1975 9
1976 15
1977 13
1978 8
1979 17
1980 15
1981 20
1982 19
1983 22
1984 28
1985 30
1986 32
1987 20
1988 41
1989 46
1990 42
1991 54
1992 51
1993 74
1994 93
1995 113
1996 101
1997 128
1998 131
1999 124
2000 163
2001 152
2002 156
2003 160
2004 188
2005 189
2006 195
2007 210
2008 221
2009 242
2010 292
2011 324
2012 365
2013 413
2014 416
2015 428
2016 489
2017 519
2018 633
2019 813
2020 1120
2021 1338
2022 1398
2023 1390
2024 639

Text availability

Article attribute

Article type

Publication date

Search Results

12,131 results

Results by year

Filters applied: . Clear all
Page 2
Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies.
Sholler DJ, Schoene L, Spindle TR. Sholler DJ, et al. Curr Addict Rep. 2020 Sep;7(3):405-412. doi: 10.1007/s40429-020-00326-8. Epub 2020 Jul 25. Curr Addict Rep. 2020. PMID: 33585159 Free PMC article.
PURPOSE OF REVIEW: Global policy changes have increased access to products containing cannabidiol (CBD), a primary constituent of hemp and cannabis. The CBD product industry has experienced tremendous growth, in part, because CBD is widely touted as an effect …
PURPOSE OF REVIEW: Global policy changes have increased access to products containing cannabidiol (CBD), a primary constituent of hem …
Towards Better Delivery of Cannabidiol (CBD).
Millar SA, Maguire RF, Yates AS, O'Sullivan SE. Millar SA, et al. Pharmaceuticals (Basel). 2020 Aug 28;13(9):219. doi: 10.3390/ph13090219. Pharmaceuticals (Basel). 2020. PMID: 32872355 Free PMC article. Review.
Cannabidiol (CBD) has substantial therapeutic potential, but its development as an effective drug by the pharmaceutical industry is hindered by intrinsic characteristics such as low bioavailability, low water solubility, and variable pharmacokinetic profiles. ...This revie …
Cannabidiol (CBD) has substantial therapeutic potential, but its development as an effective drug by the pharmaceutical industry is h …
Cannabidiol (CBD).
Meissner H, Cascella M. Meissner H, et al. 2024 May 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 May 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32310508 Free Books & Documents.
This activity focuses on cannabidiol's (CBD) role in managing refractory epilepsy. Participants will explore indications, actions, and contraindications pertinent to CBD's efficacy in managing Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. …
This activity focuses on cannabidiol's (CBD) role in managing refractory epilepsy. Participants will explore indications, actions, an …
Cannabidiol Adverse Effects and Toxicity.
Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardò FP. Huestis MA, et al. Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901. Curr Neuropharmacol. 2019. PMID: 31161980 Free PMC article. Review.
Studies defining CBD's beneficial effects were included to provide balance in estimating risk/benefit. ...Human CBD studies for epilepsy and psychiatric disorders reported CBD-induced drug-drug interactions, hepatic abnormalities, diarrhea, fatigue, vomiting, …
Studies defining CBD's beneficial effects were included to provide balance in estimating risk/benefit. ...Human CBD studies fo …
Use of cannabidiol (CBD) for the treatment of cognitive impairment in psychiatric and neurological illness: A narrative review.
Ortiz R, Rueda S, Di Ciano P. Ortiz R, et al. Exp Clin Psychopharmacol. 2023 Oct;31(5):978-988. doi: 10.1037/pha0000659. Epub 2023 May 1. Exp Clin Psychopharmacol. 2023. PMID: 37126037 Review.
Cannabidiol (CBD) is one of the major phytocannabinoids present in the cannabis plant, with no acute psychotropic effects and a favorable safety and abuse liability profile. ...Preclinical, but not clinical, studies found evidence for an improvement in cognitive performanc …
Cannabidiol (CBD) is one of the major phytocannabinoids present in the cannabis plant, with no acute psychotropic effects and a favor …
Cautious Hope for Cannabidiol (CBD) in Rheumatology Care.
Fitzcharles MA, Clauw DJ, Häuser W. Fitzcharles MA, et al. Arthritis Care Res (Hoboken). 2023 Jun;75(6):1371-1375. doi: 10.1002/acr.24176. Epub 2023 Mar 14. Arthritis Care Res (Hoboken). 2023. PMID: 32144889 Review.
Cannabidiol (CBD), a major metabolite of Cannabis sativa, is popularized as a medicinal product, with potential for analgesic, antiinflammatory, and antioxidant effects. CBD may hold promise as a treatment in rheumatic diseases, but evidence to date remains preclini …
Cannabidiol (CBD), a major metabolite of Cannabis sativa, is popularized as a medicinal product, with potential for analgesic, antiin …
Clinicians' Guide to Cannabidiol and Hemp Oils.
VanDolah HJ, Bauer BA, Mauck KF. VanDolah HJ, et al. Mayo Clin Proc. 2019 Sep;94(9):1840-1851. doi: 10.1016/j.mayocp.2019.01.003. Epub 2019 Aug 22. Mayo Clin Proc. 2019. PMID: 31447137 Free article. Review.
Care must be taken when directing patients toward CBD products because there is little regulation, and studies have found inaccurate labeling of CBD and tetrahydrocannabinol quantities. This article provides an overview of the scientific work on cannabinoids, CBD
Care must be taken when directing patients toward CBD products because there is little regulation, and studies have found inaccurate …
CBD for the treatment of pain: What is the evidence?
Svensson CK. Svensson CK. J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e80-e83. doi: 10.1016/j.japh.2020.06.009. Epub 2020 Jul 4. J Am Pharm Assoc (2003). 2020. PMID: 32636158
Cannabidiol (CBD) has become widely available owing to recent changes in federal and state regulations. ...Thus, there is a physiological basis to investigate CBD for the treatment of pain. Although CBD has been found to reduce pain in several animal models o …
Cannabidiol (CBD) has become widely available owing to recent changes in federal and state regulations. ...Thus, there is a physiolog …
Antioxidative and Anti-Inflammatory Properties of Cannabidiol.
Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Atalay S, et al. Antioxidants (Basel). 2019 Dec 25;9(1):21. doi: 10.3390/antiox9010021. Antioxidants (Basel). 2019. PMID: 31881765 Free PMC article. Review.
Cannabidiol (CBD) is one of the main pharmacologically active phytocannabinoids of Cannabis sativa L. ...Here, we review the main biological effects of CBD, and its synthetic derivatives, focusing on the cellular, antioxidant, and anti-inflammatory properties of …
Cannabidiol (CBD) is one of the main pharmacologically active phytocannabinoids of Cannabis sativa L. ...Here, we review the main bio …
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S, Kloiber S, Le Foll B. Elsaid S, et al. Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28. Prog Mol Biol Transl Sci. 2019. PMID: 31601406 Review.
Moreover, CBD was shown to reduce addictive effects of some drugs of abuse. ...Currently, there are no human studies that investigated the effects of CBD in either Alzheimer's disease or unipolar depression, warranting further investigation in this area, considering …
Moreover, CBD was shown to reduce addictive effects of some drugs of abuse. ...Currently, there are no human studies that investigate …
12,131 results
You have reached the last available page of results. Please see the User Guide for more information.